BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12513664)

  • 1. Genomics: an in vitro toxicology point of view.
    Corvi R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():129-31. PubMed ID: 12513664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicogenomics; transcript profiling and potential application to chemical allergy.
    Pennie WD; Kimber I
    Toxicol In Vitro; 2002 Jun; 16(3):319-26. PubMed ID: 12020605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
    Zuang V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology.
    Fielden MR; Zacharewski TR
    Toxicol Sci; 2001 Mar; 60(1):6-10. PubMed ID: 11222867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models.
    Bremer S; Pellizzer C; Adler S; Paparella M; de Lange J
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():107-9. PubMed ID: 12513659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECVAM's activities on computer modelling and integrated testing.
    Worth AP
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():133-7. PubMed ID: 12513665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of toxicogenomics.
    Hamadeh HK; Amin RP; Paules RS; Afshari CA
    Curr Issues Mol Biol; 2002 Apr; 4(2):45-56. PubMed ID: 11931569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA microarrays as a tool in toxicogenomics.
    de Longueville F; Bertholet V; Remacle J
    Comb Chem High Throughput Screen; 2004 May; 7(3):207-11. PubMed ID: 15134526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
    Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion.
    Jennings P; Aydin S; Bennett J; McBride R; Weiland C; Tuite N; Gruber LN; Perco P; Gaora PO; Ellinger-Ziegelbauer H; Ahr HJ; Kooten CV; Daha MR; Prieto P; Ryan MP; Pfaller W; McMorrow T
    Toxicol In Vitro; 2009 Apr; 23(3):486-99. PubMed ID: 19159671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialogue and collaboration: a personal view on laboratory animal welfare developments in general, and on ECVAM's first decade in particular.
    Koëter HB
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():207-10. PubMed ID: 12513676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics. Toxicologists brace for genomics revolution.
    Lovett RA
    Science; 2000 Jul; 289(5479):536-7. PubMed ID: 10939962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of QSAR and in vitro toxicology.
    Barratt MD
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):459-65. PubMed ID: 9599692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of genomics to the definition of the molecular basis for toxicity.
    Pennie WD; Woodyatt NJ; Aldridge TC; Orphanides G
    Toxicol Lett; 2001 Mar; 120(1-3):353-8. PubMed ID: 11323194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implications of microarray technology for animal use in scientific research.
    Jenkins ES; Broadhead C; Combes RD
    Altern Lab Anim; 2002; 30(4):459-65. PubMed ID: 12234244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECVAM's activities on biologicals.
    Halder M; Balls M; Hendriksen C; Cussler K
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():125-8. PubMed ID: 12513663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.